{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:58:03Z","timestamp":1776376683441,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jnci.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,2,21]],"date-time":"2015-02-21T20:47:06Z","timestamp":1424551626000},"page":"11-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening"],"prefix":"10.1186","volume":"27","author":[{"given":"Tamer A.","family":"Elbedewy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam Eldin A.","family":"Elashtokhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enaam S.","family":"Rabee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamal E.","family":"Kheder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jnci.2015.01.004_b0005","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4065\/82.8.967","article-title":"Natural history of hepatitis B virus infection: an update for clinicians","volume":"82","author":"Pungpapoong","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jnci.2015.01.004_b0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4254\/wjh.v4.i3.74","article-title":"Hepatitis B: epidemiology and prevention in developing countries","volume":"27","author":"Franco","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jnci.2015.01.004_b0015","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.3748\/wjg.15.4986","article-title":"Controversies about occult hepatitis B virus infection","volume":"15","author":"Ozaslan","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jnci.2015.01.004_b0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2008.01.023","article-title":"Occult hepatitis B virus in liver tissue of individuals without hepatic disease","volume":"48","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jnci.2015.01.004_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2257.2000.00265.x","article-title":"Genomic screening for blood-borne viruses in transfusion settings","volume":"22","author":"Allain","year":"2000","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.jnci.2015.01.004_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/CCLM.2010.002","article-title":"The role of anti-core antibody response in the detection of occult hepatitis B virus infection","volume":"48","author":"Urbani","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jnci.2015.01.004_b0035","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cgh.2009.06.027","article-title":"Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression","volume":"7","author":"Palmore","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jnci.2015.01.004_b0040","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00277-009-0806-7","article-title":"Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients","volume":"89","author":"Pei","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jnci.2015.01.004_b0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.bmt.1704457","article-title":"Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation","volume":"33","author":"Kn\u00f6ll","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jnci.2015.01.004_b0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2015.01.004_b0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s15010-009-9019-1","article-title":"Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy","volume":"38","author":"Francisci","year":"2009","journal-title":"Infection"},{"key":"10.1016\/j.jnci.2015.01.004_b0060","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.jnci.2015.01.004_b0065","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/annonc\/8.suppl_2.S11","article-title":"Principles of the revised European\u2013American lymphoma classification (from the International Lymphoma Study Group)","volume":"8","author":"Harris","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jnci.2015.01.004_b0070","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2015.01.004_b0075","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The international non-Hodgkin\u2019s lymphoma prognostic factors project","volume":"329","author":"Shipp","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jnci.2015.01.004_b0080","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2015.01.004_b0085","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.jnci.2015.01.004_b0090","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jnci.2015.01.004_b0095","unstructured":"NCCN Clinical Practice Guidelines in Oncology\u2122, Non-Hodgkin\u2019s lymphomas, v 3. Available at: http:\/\/www.nccn.org\/pro fessionals\/physician_gls\/pdf\/nhl.pdf; 2012 [accessed 12.07.12]."},{"key":"10.1016\/j.jnci.2015.01.004_b0100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2004.05.161","article-title":"Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy","volume":"22","author":"Yeo","year":"2004","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jnci.2015.01.004_b0105","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/JCM.27.9.1930-1933.1989","article-title":"Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique","volume":"27","author":"Kaneko","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jnci.2015.01.004_b0110","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.jnci.2015.01.004_b0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00277-003-0825-8","article-title":"Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy","volume":"83","author":"Leaw","year":"2004","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jnci.2015.01.004_b0120","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2008-10-163493","article-title":"How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation","volume":"113","author":"Liang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jnci.2015.01.004_b0125","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/gut.2009.195834","article-title":"Managing HBV in patients with impaired immunity","volume":"59","author":"Wursthorn","year":"2010","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jnci.2015.01.004_b0130","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1053\/j.gastro.2003.09.026","article-title":"Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy","volume":"125","author":"Lau","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnci.2015.01.004_b0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jnci.2015.01.004_b0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.dld.2006.12.017","article-title":"Prophylaxis and treatment of hepatitis B in immunocompromised patients","volume":"39","author":"Marzano","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jnci.2015.01.004_b0145","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jnci.2015.01.004_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcv.2013.03.010","article-title":"Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis","volume":"57","author":"Dong","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jnci.2015.01.004_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnci.2015.01.004_b0160","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1002\/cncr.25253","article-title":"Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma","volume":"116","author":"Matsue","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jnci.2015.01.004_b0165","first-page":"376","article-title":"Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy","volume":"17","author":"Cheung","year":"2011","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.jnci.2015.01.004_b0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/030089161209800207","article-title":"Reactivation of hepatitis B virus replication due to cytotoxic therapy: a five-year prospective study","volume":"98","author":"Francisci","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.jnci.2015.01.004_b0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-230X-14-31","article-title":"Management of the HBV reactivation in isolated HBcAb positive patients affected with non Hodgkin lymphoma","volume":"14","author":"Masarone","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"37","key":"10.1016\/j.jnci.2015.01.004_b0180","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3748\/wjg.v19.i37.6214","article-title":"Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt","volume":"19","author":"Elkady","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jnci.2015.01.004_b0185","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4254\/wjh.v5.i7.387","article-title":"Hepatitis B virus reactivation in hepatitis B virus surface antigen negative patients receiving immunosuppression: a hidden threat","volume":"5","author":"Zachou","year":"2013","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.jnci.2015.01.004_b0190","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jnci.2015.01.004_b0195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1473-3099(02)00345-6","article-title":"Occult hepatitis B","volume":"2","author":"Torbenson","year":"2002","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036215000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036215000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T06:04:32Z","timestamp":1598767472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110036215000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1110036215000060"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2015.01.004","relation":{},"ISSN":["1110-0362"],"issn-type":[{"value":"1110-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}